Search
for
Sort by
Research 91–120 of 115
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy
- Skin Cyst: A Pathological Dead-End With a New Twist of Morphogenetic Potentials in Organoid Cultures
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Advancing Design Strategy of PROTACs for Cancer Therapy
- Cancer-Related Alopecia: From Etiologies to Global Management
- An exclusive review of melatonin effects on mammalian melanocytes and melanoma
- Diagnosis and Management of Melanoma of the Scalp: A Review of the Literature
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China
- Dermoscopy to the rescue
- Manifestation of pityriasis amiantacea following initiation of minoxidil
- Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems
- Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities
- Research Progress on Construction Technology of 3D Human Skin Models and Its Application Prospects in Dermatology
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Multi-omics analysis unveils the role of cancer-associated fibroblasts in cutaneous squamous cell carcinoma
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- RASopathic Skin Eruptions during Vemurafenib Therapy
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- Vemurafenib-induced pityriasis amiantacea: a case report
- Correction: RASopathic Skin Eruptions during Vemurafenib Therapy
- Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma